PDF herunterladen
CC BY-NC-ND 4.0 · Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery 2022; 41(02): e212-e216
DOI: 10.1055/s-0041-1740166
Case Report

Thermocoagulation Treatment of a Patient with Obsessive Compulsive Disorder and Substance Use Disorder: Case Report

Tratamento por termocoagulação de paciente com transtorno obsessivo-compulsivo e transtorno por uso de substâncias: Relato de caso
Natalia Guisolphi 
1   School of Medicine, Pontifícia Universidade Católica de Goiás, Goiânia, GO, Brazil
,
Isabela Garcia Bessa 
1   School of Medicine, Pontifícia Universidade Católica de Goiás, Goiânia, GO, Brazil
,
Ledismar José da Silva 
1   School of Medicine, Pontifícia Universidade Católica de Goiás, Goiânia, GO, Brazil
› Institutsangaben
› Weitere Informationen
   Lizenzen und Reprints

Abstract

Obsessive compulsive disorder (OCD) is a possible cause associated with substance use disorder (SUD), a set of physical, psychological, behavioral, and cognitive phenomena related to the use of one or more chemical substances as a priority in a person's life that compromises quality of life. Since they can share the same neuronal network, this serves as a basis for neurosurgical procedures in cases refractory to conventional therapies. A 31-year-old male patient with a history of OCD and SUD refractory to conventional therapies underwent bilateral ablative stereotactic neurosurgery of the anterior limb of the internal capsule, the subgenual cingulate region, the nucleus accumbens, and the cingulate gyrus. Up to 33 months after the the procedure, the patient showed an absolute improvement in OCD and SUD and reported lack of withdrawal signs or symptoms and/or need to use drugs. In recent years, ablative neurosurgery has proven to be an alternative to OCD refractoriness, with long-term benefits. In the case analyzed, ablative stereotactic neurosurgery was effective in controlling both the signs and symptoms triggered by OCD, as well as those of anxiety and stress.

Resumo

O transtorno obsessivo-compulsivo (TOC) é uma possível causa associada ao transtorno por uso de substâncias (TUS), um conjunto de fenômenos físicos, psicológicos, comportamentais e cognitivos relacionados ao uso de uma ou mais substâncias químicas como prioridade na vida de uma pessoa que compromete sua qualidade de vida. Como estes transtornos podem compartilhar a mesma rede neuronal, isto serve de base para procedimentos neurocirúrgicos em casos refratários às terapias convencionais. Um paciente do sexo masculino de 31 anos com história de TOC e TUS refratários às terapias convencionais foi submetido a neurocirurgia estereotáxica ablativa bilateral do braço anterior da cápsula interna, da área subgenual, do núcleo accumbens e do giro do cíngulo. Até 33 meses após o procedimento, o paciente apresentou melhora absoluta do TOC e do TUS e relatou ausência de sinais ou sintomas de abstinência e/ou necessidade de uso de medicamentos. Nos últimos anos, a neurocirurgia ablativa tem se mostrado uma alternativa à refratariedade do TOC, com benefícios a longo prazo. No caso analisado, a neurocirurgia estereotáxica ablativa foi eficaz no controle tanto dos sinais e sintomas desencadeados pelo TOC como dos de ansiedade e estresse.

Keywords

stereotaxic technique - substance-related disorder - obsessive-compulsive disorder - neurosurgery - psychiatry - quality of life

Palavras-chave

técnica estereotáxica - transtorno relacionado ao uso de substâncias - transtorno obsessivo-compulsivo - neurocirurgia - psiquiatria - qualidade de vida


Publikationsverlauf

Eingereicht: 16. Juli 2021

Angenommen: 30. Juli 2021

Artikel online veröffentlicht:
24. Januar 2022

© 2022. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Brock H, Hany M. Obsessive-compulsive disorder. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2021. . Access on: May 25, 2021 at: https://www.ncbi.nlm.nih.gov/books/NBK553162/
    Google Scholar
  • 2 Figee M, Pattij T, Willuhn I. et al. Compulsivity in obsessive-compulsive disorder and addictions. Eur Neuropsychopharmacol 2016; 26 (05) 856-868
    CrossrefPubMedGoogle Scholar
  • 3 Colon-Rivera H, Balasanova A. What is a substance use disorder?. Washington, DC: American Psychiatric Association; 2017. . Access on: May 25, 2021 at: https://www.psychiatry.org/patients-families/addiction/what-is-addiction
    Google Scholar
  • 4 United Nations. World Drug Report 2020. Vienna: Division for Policy Analysis and Public Affairs, United Nations Office on Drugs and Crime; 2020 . Access on: May 25, 2021 at: https://wdr.unodc.org/wdr2020/field/WDR20_Booklet_2.pdf
    PubMedGoogle Scholar
  • 5 Santos PLM, Curti RO, Silva LJ. Neurosurgical treatment for drug addiction: systematic review. Arq Bras Neurocir 2020; 39 (02) 116-124
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 6 Lai Y, Wang T, Zhang C. et al. Effectiveness and safety of neuroablation for severe and treatment-resistant obsessive-compulsive disorder: a systematic review and meta-analysis. J Psychiatry Neurosci 2020; 45 (05) 356-369
    CrossrefPubMedGoogle Scholar
  • 7 Nuttin B, Wu H, Mayberg H. et al. Consensus on guidelines for stereotactic neurosurgery for psychiatric disorders. J Neurol Neurosurg Psychiatry 2014; 85 (09) 1003-1008
    CrossrefPubMedGoogle Scholar
  • 8 Balachander S, Arumugham SS, Srinivas D. Ablative neurosurgery and deep brain stimulation for obsessive-compulsive disorder. Indian J Psychiatry 2019; 61 (Suppl. 01) S77-S84
    PubMedGoogle Scholar
  • 9 World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310 (20) 2191-2194
    Google Scholar
  • 10 Pepper J, Hariz M, Zrinzo L. Deep brain stimulation versus anterior capsulotomy for obsessive-compulsive disorder: a review of the literature. J Neurosurg 2015; 122 (05) 1028-1037
    CrossrefPubMedGoogle Scholar
  • 11 Kumar KK, Appelboom G, Lamsam L. et al. Comparative effectiveness of neuroablation and deep brain stimulation for treatment-resistant obsessive-compulsive disorder: a meta-analytic study. J Neurol Neurosurg Psychiatry 2019; 90 (04) 469-473
    CrossrefPubMedGoogle Scholar
  • 12 Pallanti S, Quercioli L. Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30 (03) 400-412
    CrossrefPubMedGoogle Scholar
  • 13 Goodman WK, Price LH, Rasmussen SA. et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989; 46 (11) 1006-1011
    CrossrefPubMedGoogle Scholar
  • 14 Hassan O, Phan S, Wiecks N, Joaquin C, Bondarenko V. Outcomes of deep brain stimulation surgery for substance use disorder: a systematic review. Neurosurg Rev. Updated October. 2020 . Access on: May 25, 2021 at: https://link.springer.com/article/10.1007%2Fs10143-020-01415-y
    PubMedGoogle Scholar
  • 15 Zhu R, Zhang Y, Wang T. et al. Deep brain stimulation of nucleus accumbens with anterior capsulotomy for drug addiction: a case report. Stereotact Funct Neurosurg 2020; 98 (05) 345-349
    CrossrefPubMedGoogle Scholar
  • 16 Gonçalves-Ferreira A, do Couto FS, Rainha Campos A, Lucas Neto LP, Gonçalves-Ferreira D, Teixeira J. Deep brain stimulation for refractory cocaine dependence. Biol Psychiatry 2016; 79 (11) e87-e89
    CrossrefPubMedGoogle Scholar
  • 17 Ma S, Zhang C, Yuan TF. et al. Neurosurgical treatment for addiction: lessons from an untold story in China and a path forward. Natl Sci Rev 2020; 7 (03) 702-712 DOI: 10.1093/nsr/nwz207.
    CrossrefPubMedGoogle Scholar